So-Young International Inc. (SY)
NASDAQ: SY · IEX Real-Time Price · USD
1.240
+0.020 (1.64%)
Apr 25, 2024, 4:30 PM EDT - Market closed
So-Young International Market Cap
So-Young International has a market cap or net worth of $132.46 million as of April 25, 2024. Its market cap has decreased by -55.77% in one year.
Market Cap
132.46M
Enterprise Value
-32.73M
1-Year Change
-55.77%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since May 2, 2019, So-Young International's market cap has decreased from $1.82B to $132.46M, a decrease of -92.74%. That is a compound annual growth rate of -40.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 121.60M | 1.67% |
Apr 24, 2024 | 119.60M | -1.64% |
Apr 23, 2024 | 121.60M | -6.03% |
Apr 22, 2024 | 129.40M | 13.81% |
Apr 19, 2024 | 113.70M | -3.40% |
Apr 18, 2024 | 117.70M | 2.62% |
Apr 17, 2024 | 114.70M | 2.14% |
Apr 16, 2024 | 112.30M | 4.08% |
Apr 15, 2024 | 107.90M | -5.93% |
Apr 12, 2024 | 114.70M | 2.59% |
Apr 11, 2024 | 111.80M | - |
Apr 10, 2024 | 111.80M | -5.01% |
Apr 9, 2024 | 117.70M | 2.62% |
Apr 8, 2024 | 114.70M | 0.88% |
Apr 5, 2024 | 113.70M | - |
Apr 4, 2024 | 113.70M | - |
Apr 3, 2024 | 113.70M | 1.70% |
Apr 2, 2024 | 111.80M | - |
Apr 1, 2024 | 111.80M | 4.58% |
Mar 28, 2024 | 106.90M | 0.94% |
Mar 27, 2024 | 105.90M | 0.95% |
Mar 26, 2024 | 104.90M | 1.84% |
Mar 25, 2024 | 103.00M | -0.87% |
Mar 22, 2024 | 103.90M | 1.86% |
Mar 21, 2024 | 102.00M | -0.97% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Augmedix | 138.91M |
Syros Pharmaceuticals | 134.12M |
Delcath Systems | 133.87M |
Sagimet Biosciences | 133.08M |
DBV Technologies | 132.96M |
Outset Medical | 128.79M |
Omega Therapeutics | 128.51M |
Molecular Partners AG | 127.80M |